Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Kirkwood

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|July 8, 1998
Adjuvant IFN alpha2 therapy of melanomaJ M Kirkwood
Immunology Series|January 1, 1994
The role of interferons in the therapy of melanomaJ M Kirkwood
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapiesJ M Kirkwood
Seminars in Oncology|October 1, 1991
Studies of interferons in the therapy of melanomaJ M Kirkwood
British Journal of Cancer|May 19, 2000
Adjuvant interferon in the treatment of melanomaJ M Kirkwood
Current Opinion in Oncology|March 1, 1994
Systemic therapy of melanomaJ M Kirkwood
Current Opinion in Oncology|April 1, 1992
Preclinical studies, experimental therapeutics, and clinical management of advanced melanomaJ M Kirkwood
Cancer Treatment Reports|January 1, 1982
Phase II trial of mitolactol in patients with metastatic melanomaW Medina, J M Kirkwood
Seminars in Oncology|September 1, 1986
Potential applications of the interferons in oncology: lessons drawn from studies of human melanomaJ M Kirkwood, M Ernstoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Granulocyte-macrophage colony-stimulating factor: another cytokine with adjuvant therapeutic benefit in melanoma?D Lawson, J M Kirkwood
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|July 8, 1998
Adjuvant IFN alpha2 therapy of melanomaJ M Kirkwood
Immunology Series|January 1, 1994
The role of interferons in the therapy of melanomaJ M Kirkwood
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapiesJ M Kirkwood
Seminars in Oncology|October 1, 1991
Studies of interferons in the therapy of melanomaJ M Kirkwood
British Journal of Cancer|May 19, 2000
Adjuvant interferon in the treatment of melanomaJ M Kirkwood
Current Opinion in Oncology|March 1, 1994
Systemic therapy of melanomaJ M Kirkwood
Current Opinion in Oncology|April 1, 1992
Preclinical studies, experimental therapeutics, and clinical management of advanced melanomaJ M Kirkwood
Cancer Treatment Reports|January 1, 1982
Phase II trial of mitolactol in patients with metastatic melanomaW Medina, J M Kirkwood
Seminars in Oncology|September 1, 1986
Potential applications of the interferons in oncology: lessons drawn from studies of human melanomaJ M Kirkwood, M Ernstoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Granulocyte-macrophage colony-stimulating factor: another cytokine with adjuvant therapeutic benefit in melanoma?D Lawson, J M Kirkwood
Pageof 18